APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the Pivotal Bioequivalence study for their proprietary Ondansetron RapidFilm™

2015-01-15T18:21:28+00:00 Applied Pharma Research (APR)